Edwards Lifesciences Corp

Avantax Planning Partners, Inc. EW

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/5/2026

Shares

2,447

Value ($000)

209

Weight

0.0%

2019 Q4 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/5/2026	209	0.0%	2,447	12/31/2025
2024 Q2	8/9/2024	216	0.0%	2,338	6/30/2024
2024 Q1	5/3/2024	224	0.0%	2,344	3/31/2024
2023 Q2	7/18/2023	228	0.0%	2,416	6/30/2023
2022 Q2	7/18/2022	247	0.0%	2,594	6/30/2022
2022 Q1	5/9/2022	305	0.0%	2,588	3/31/2022
2021 Q4	1/28/2022	339	0.0%	2,616	12/31/2021
2021 Q3	10/27/2021	293	0.0%	2,588	9/30/2021
2021 Q2	8/10/2021	268	0.0%	2,588	6/30/2021
2020 Q4	2/4/2021	218	0.0%	2,385	12/31/2020
2020 Q3	10/28/2020	243	0.0%	3,042	9/30/2020
2020 Q2	7/15/2020	210	0.0%	3,042	6/30/2020
2019 Q4	1/15/2020	237	0.0%	1,015	12/31/2019